Risk of hepatocellular carcinoma after hepatitis C virus cure

Risk of hepatocellular carcinoma after hepatitis C virus cure

Hepatitis C virus (HCV) is a significant cause of hepatocellular carcinoma (HCC). The direct-acting antivirals marked a new era of HCV therapy and are associated with greater than 95% cure rate. Successful treatment of chronic hepatitis C greatly reduces the risk of HCC. A proportion of patients, es...

Full description

Bibliographic Details
Main Authors: Ali, M.J (Author), Chen, H.-W (Author), Hanif, H. (Author), Khan, M.M (Author), Luna-Cuadros, M.A (Author), Tan-Yeung Lau, D. (Author)
Format: Article
Language:English
Published: Baishideng Publishing Group Inc 2022
Subjects:
alcohol
alcohol consumption
Antiviral Agents
antiviral therapy
antivirus agent
aspartate aminotransferase to platelet ratio index
boceprevir
cancer risk
Carcinoma, Hepatocellular
chronic hepatitis C
complication
daclatasvir
diabetes mellitus
drug efficacy
early diagnosis
elbasvir plus grazoprevir
fatty liver
Fibrosis markers
glecaprevir plus pibrentasvir
Hepacivirus
hepatitis C
Hepatitis C
Hepatitis C virus cure
Hepatitis C virus genotype 1
Hepatitis C virus genotype 2
Hepatitis C virus genotype 3
Hepatitis C virus genotype 4
Hepatitis C virus genotype 5
Hepatitis C virus genotype 6
Hepatitis C, Chronic
Hepatocellular carcinoma
Hepatocellular carcinoma risk models
high risk patient
human
Humans
ledipasvir plus sofosbuvir
liver carcinogenesis
liver cell carcinoma
liver cirrhosis
Liver Cirrhosis
liver fibrosis
Liver Neoplasms
liver tumor
nonalcoholic fatty liver
nonhuman
peginterferon
peginterferon alpha
prediction
prevalence
remission
Review
ribavirin
risk reduction
sofosbuvir
sofosbuvir plus velpatasvir
sofosbuvir plus velpatasvir plus voxilaprevir
sustained virologic response
Sustained Virologic Response
telaprevir
transient elastography
Transient elastography
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items